The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intralesional therapy, limb infusion/perfusion, and immune checkpoint inhibitors as first-line therapy in surgically unresectable melanoma in-transit metastases.
 
Danielle K DePalo
No Relationships to Disclose
 
Syeda Mahrukh Hussnain Naqvi
No Relationships to Disclose
 
David W. Ollila
Stock and Other Ownership Interests - CVS; Johnson & Johnson; Pfizer
 
Tina J. Hieken
Speakers' Bureau - Skyline Diagnostics
Research Funding - Genentech/Roche (Inst); Skyline Diagnostics (Inst)
 
Matthew Stephen Block
Research Funding - Alkermes; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Marker, Inc. (Inst); Merck (Inst); nference; Pharmacyclics (Inst); Regeneron; Sorrento Therapeutics (Inst); TILT Biotherapeutics; Transgene (Inst); Viewpoint Molecular Targeting
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting
 
Winan J. van Houdt
Consulting or Advisory Role - Amgen (Inst); belpharma (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Boehringer Ingelheim (Inst); MSD (Inst); Novartis (Inst)
 
Michel W.J.M. Wouters
No Relationships to Disclose
 
Nethanel Asher
No Relationships to Disclose
 
Kristy Kummerow Broman
No Relationships to Disclose
 
Zoey Duncan
No Relationships to Disclose
 
Matilda Anderson
No Relationships to Disclose
 
David E. Gyorki
Honoraria - BMSi; MSD Oncology; Novartis
Travel, Accommodations, Expenses - Amgen
 
John T. Vetto
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I)
Speakers' Bureau - Castle Biosciences
Travel, Accommodations, Expenses - Castle Biosciences
 
Jane Yuet Ching Hui
No Relationships to Disclose
 
Robyn P.M. Saw
Honoraria - BMS GmbH & Co. KG; Merck Sharp & Dohme; Novartis; Qbiotics
Consulting or Advisory Role - MSD; Qbiotics
Speakers' Bureau - Bristol-Myers Squibb/Sanofi; Novartis
Research Funding - Qbiotics
 
Serigne N. Lo
No Relationships to Disclose
 
Youngchul Kim
No Relationships to Disclose
 
Alexander Christopher Jonathan Van Akkooi
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Provectus Biopharmaceuticals; Sanofi (Inst); Sirius Medical (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics; Skyline Diagnostics (Inst)
 
Jonathan S. Zager
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Honoraria - Amgen; Castle Biosciences; Merck; Pfizer; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - Castle Biosciences; Delcath Systems; Philogen; Sanofi/Regeneron
Speakers' Bureau - Pfizer; Sun Pharma
Research Funding - Castle Biosciences (Inst); Delcath Systems (Inst); NeraCare GmbH (Inst); Philogen (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - US Patent 10,583,246
Expert Testimony - Bubalo Law; McGowan, Hood, Felder & Phillips, LLC
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Merck